Hiroshi Kodaira

2.1k total citations
45 papers, 1.5k citations indexed

About

Hiroshi Kodaira is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Hiroshi Kodaira has authored 45 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Oncology and 7 papers in Biomaterials. Recurrent topics in Hiroshi Kodaira's work include Cancer therapeutics and mechanisms (7 papers), Nanoparticle-Based Drug Delivery (7 papers) and RNA Interference and Gene Delivery (4 papers). Hiroshi Kodaira is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Nanoparticle-Based Drug Delivery (7 papers) and RNA Interference and Gene Delivery (4 papers). Hiroshi Kodaira collaborates with scholars based in Japan, United States and China. Hiroshi Kodaira's co-authors include Yuichi Sugiyama, Hiroyuki Kusuhara, Eiichi Fuse, Junko Ushiki, S. Spector, Tadanori Mayumi, Yasuo Tsutsumi, Haruhiko Kamada, Shin‐ichi Tsunoda and Shinsaku Nakagawa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Hiroshi Kodaira

42 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Kodaira Japan 22 526 440 237 187 173 45 1.5k
Zohreh Mostafavi‐Pour Iran 24 877 1.7× 208 0.5× 108 0.5× 65 0.3× 123 0.7× 123 2.3k
Baoan Chen China 22 644 1.2× 586 1.3× 138 0.6× 62 0.3× 113 0.7× 82 1.6k
Steve Weitman United States 23 1.2k 2.3× 538 1.2× 322 1.4× 56 0.3× 59 0.3× 36 2.5k
A. Trouet Belgium 21 749 1.4× 422 1.0× 220 0.9× 54 0.3× 65 0.4× 76 1.6k
Letizia Porcelli Italy 25 932 1.8× 720 1.6× 148 0.6× 47 0.3× 88 0.5× 71 1.8k
Qin Chen China 22 726 1.4× 218 0.5× 118 0.5× 60 0.3× 99 0.6× 69 1.8k
Jason D. Lickliter Australia 25 660 1.3× 317 0.7× 69 0.3× 40 0.2× 190 1.1× 93 1.7k
John W. Marks United States 27 1.3k 2.6× 388 0.9× 70 0.3× 92 0.5× 55 0.3× 58 2.4k
Yutaka Tsukada Japan 25 952 1.8× 430 1.0× 112 0.5× 41 0.2× 303 1.8× 97 2.3k

Countries citing papers authored by Hiroshi Kodaira

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Kodaira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Kodaira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Kodaira more than expected).

Fields of papers citing papers by Hiroshi Kodaira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Kodaira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Kodaira. The network helps show where Hiroshi Kodaira may publish in the future.

Co-authorship network of co-authors of Hiroshi Kodaira

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Kodaira. A scholar is included among the top collaborators of Hiroshi Kodaira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Kodaira. Hiroshi Kodaira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Suzuki, Yasuhiro, Mari Tanigawa, Kana Asano, et al.. (2022). Targeted delivery to macrophages and dendritic cells by chemically modified mannose ligand-conjugated siRNA. Nucleic Acids Research. 50(9). 4840–4859. 40 indexed citations
3.
Yamamoto, Keisuke, Tomohiro Tamura, Masahiro Matsubara, et al.. (2019). Development of a novel class of peroxisome proliferator-activated receptor (PPAR) gamma ligands as an anticancer agent with a unique binding mode based on a non-thiazolidinedione scaffold. Bioorganic & Medicinal Chemistry. 27(22). 115122–115122. 14 indexed citations
4.
Fujisawa, Takao, M Takahashi, Hiroshi Kodaira, et al.. (2015). The ASK1-specific inhibitors K811 and K812 prolong survival in a mouse model of amyotrophic lateral sclerosis. Human Molecular Genetics. 25(2). 245–253. 38 indexed citations
5.
Nakagawa, Motoo, Katsuhiro Miura, Machiko Kusuda, et al.. (2013). The Long Lasting Lesion of Acute Methotrexate-Induced Encephalopathy Detected by Diffusion-Weighted MRI. Annals of Oncology. 24. ix86–ix86.
6.
Kodaira, Hiroshi, Hiroyuki Kusuhara, Junko Ushiki, Eiichi Fuse, & Yuichi Sugiyama. (2010). Kinetic Analysis of the Cooperation of P-Glycoprotein (P-gp/Abcb1) and Breast Cancer Resistance Protein (Bcrp/Abcg2) in Limiting the Brain and Testis Penetration of Erlotinib, Flavopiridol, and Mitoxantrone. Journal of Pharmacology and Experimental Therapeutics. 333(3). 788–796. 218 indexed citations
7.
Wu, Huali, Jeffrey R. Infante, Suzanne F. Jones, et al.. (2009). Abstract C127: Factors affecting the pharmacokinetics (PK) and pharmacodynamics (PD) of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors. Molecular Cancer Therapeutics. 8(12_Supplement). C127–C127. 3 indexed citations
8.
Kaneda, N, Akinobu Kurita, Takeshi Matsumoto, et al.. (2006). 153 POSTER Pharmacokinetics of IHL-305, a novel PEGylated liposome containing irinotecan, in rats and dogs. European Journal of Cancer Supplements. 4(12). 49–50. 1 indexed citations
9.
Yoshioka, Yasuo, Yasuo Tsutsumi, Yohei Mukai, et al.. (2004). Effective accumulation of poly(vinylpyrrolidone‐co‐vinyl laurate) into the spleen. Journal of Biomedical Materials Research Part A. 70A(2). 219–223. 11 indexed citations
10.
Tanaka, Michiko, Hiroshi Kodaira, Yukihiro Nishiyama, Tetsutaro Sata, & Yasushi Kawaguchi. (2004). Construction of recombinant herpes simplex virus type I expressing green fluorescent protein without loss of any viral genes. Microbes and Infection. 6(5). 485–493. 38 indexed citations
11.
Kodaira, Hiroshi, Yasuo Tsutsumi, Yasuo Yoshioka, et al.. (2003). The targeting of anionized polyvinylpyrrolidone to the renal system. Biomaterials. 25(18). 4309–4315. 57 indexed citations
12.
Kodaira, Hiroshi. (2003). Innovation and Market Structure. 163. 287–308. 4 indexed citations
13.
Kaneda, Yoshihisa, Yasuo Tsutsumi, Yasuo Yoshioka, et al.. (2003). The use of PVP as a polymeric carrier to improve the plasma half-life of drugs. Biomaterials. 25(16). 3259–3266. 164 indexed citations
14.
Yoshikawa, Sumiko, Hikaru Kobayashi, Shintaro Kanda, et al.. (2002). An Asian Variant of Intravascular Lymphoma Diagnosed Through Splenectomy.. Internal Medicine. 41(12). 1215–1216. 4 indexed citations
15.
Kamada, Haruhiko, Yoshihisa Kaneda, Yoko Yamamoto, et al.. (1999). Bioconjugation of bioactive peptide: Synthetic peptide YIGSR conjugated with poly(styrene comaleic acid) enhanced its inhibitory effect on lung metastasis of B16BL6 melanoma cells.. Drug Delivery System. 14(2). 129–135. 1 indexed citations
16.
Kamada, Haruhiko, Hiroshi Kodaira, Yasuo Tsutsumi, et al.. (1999). Bioconjugation of Laminin-Related Peptide YIGSR with Polyvinyl Pyrrolidone Increases Its Antimetastatic Effect Due to a Longer Plasma Half-Life. Biochemical and Biophysical Research Communications. 264(3). 763–767. 18 indexed citations
17.
Mu, Yu, Haruhiko Kamada, Yoshihisa Kaneda, et al.. (1999). Bioconjugation of Laminin Peptide YIGSR with Poly(Styrene Co-maleic Acid) Increases Its Antimetastatic Effect on Lung Metastasis of B16-BL6 Melanoma Cells. Biochemical and Biophysical Research Communications. 255(1). 75–79. 31 indexed citations
18.
Kodaira, Hiroshi, Akihiro Kume, Yoji Ogasawara, et al.. (1998). Fas and Mutant Estrogen Receptor Chimeric Gene: A Novel Suicide Vector for Tamoxifen‐inducible Apoptosis. Japanese Journal of Cancer Research. 89(7). 741–747. 11 indexed citations
19.
Shimodaira, Shigetaka, Fumihiro Ishida, Naoaki Ichikawa, et al.. (1996). Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis.. PubMed. 76(4). 545–8. 52 indexed citations
20.
Kodaira, Hiroshi, et al.. (1989). Identification of the convulsant opiate thebaine in mammalian brain.. Proceedings of the National Academy of Sciences. 86(2). 716–719. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zohreh Mostafavi‐Pour Breakdown of academic impact, for papers by Baoan Chen Breakdown of academic impact, for papers by Steve Weitman Breakdown of academic impact, for papers by A. Trouet Breakdown of academic impact, for papers by Letizia Porcelli Breakdown of academic impact, for papers by Qin Chen Breakdown of academic impact, for papers by Jason D. Lickliter Breakdown of academic impact, for papers by John W. Marks Breakdown of academic impact, for papers by Yutaka Tsukada
Rankless by CCL
2026